You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intron A

Showing 1 - 25 of 251
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
Has Results
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Advanced Cholangiocarcinoma Trial in Washington (Pembrolizumab, Sylatron)

Terminated
Has Results
  • Advanced Cholangiocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Feb 14, 2022

Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +6 more
  • Miami, Florida
  • +4 more
Dec 2, 2022

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

HIV Trial in United States (Peginterferon alfa-2b)

Completed
  • HIV Infections
  • Peginterferon alfa-2b
  • Long Beach, California
  • +14 more
Oct 28, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

Recruiting
  • Polycythemia Vera
  • London, United Kingdom
  • +1 more
Nov 29, 2021

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • P1101 + Ribavirin
  • PEG-Intron + Ribavirin
  • Beijing, China
  • +38 more
Jan 14, 2022

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Hepatitis C, Chronic Trial (Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c)

Completed
  • Hepatitis C, Chronic
  • Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
  • Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
  • (no location specified)
Aug 24, 2020

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Pittsburgh (Chemokin Modulatory Regimen (5 MU/m2), Chemokin

Terminated
Has Results
  • Colorectal Cancer
  • +3 more
  • Chemokin Modulatory Regimen (5 MU/m2)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 21, 2020

Melanoma Trial in Houston (Temozolomide, Velban, Cisplatin)

Terminated
Has Results
  • Melanoma
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Sep 1, 2020

Breastcancer, Breast Tumor Trial in United States (SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b)

Completed
Has Results
  • Breastcancer
  • Breast Neoplasm
  • SV-BR-1-GM
  • +2 more
  • Santa Rosa, California
  • +4 more
Jan 27, 2021

Melanoma Trial in Houston (Temozolomide (TMZ), Pegylated Interferon Alpha-2b (PGI))

Completed
Has Results
  • Melanoma
  • Temozolomide (TMZ)
  • Pegylated Interferon Alpha-2b (PGI)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 1, 2020

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Natural History Study of CEP290-Related Retinal Degeneration

Completed
  • Blindness
  • +7 more
    • Miami, Florida
    • +6 more
    May 18, 2022

    Chronic Myelogenous Leukemia Trial (Pegylated interferon alfa-2b, Interferon alfa-2b)

    Terminated
    Has Results
    • Chronic Myelogenous Leukemia
    • Pegylated interferon alfa-2b
    • Interferon alfa-2b
    • (no location specified)
    Jul 12, 2019

    Melanoma Trial (PEG-Intron, INTRON A)

    Terminated
    Has Results
    • Melanoma
    • PEG-Intron
    • INTRON A
    • (no location specified)
    Jul 16, 2019

    Taybi Linder Syndrome, Microcephalic Osteodysplastic Primordial Dwarfism Types I and III, Roifman Syndrome Trial in France

    Not yet recruiting
    • Taybi Linder Syndrome
    • +3 more
    • Blood samples
    • +2 more
    • Bordeaux, France
    • +5 more
    Oct 26, 2023

    Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial

    Completed
    Has Results
    • Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
    • +2 more
    • DC vaccine
    • +3 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 6, 2020

    Cough, Cerebellar Ataxia, Gastroesophageal Reflux Trial in Barcelona (To determine the presence of biallelic expansion of AAGGG

    Recruiting
    • Cough
    • +2 more
    • To determine the presence of biallelic expansion of AAGGG in RFC1 in patients with chronic cough, regardless of the presence of neurological symptoms.
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90.
    Jul 14, 2022